General Hospital of Chalkida
About General Hospital of Chalkida
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Hellenic Cardiovascular Research Society
2
Bayer
1
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
1
Clinical Trials at General Hospital of Chalkida
During the past decade, General Hospital of Chalkida conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Current Clinical Practice in the Management of Atrial Fibrillation in Greece: the MANAGE-AF Study
2011-03-01
Completed
603
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
A New Formulation of Intravenous Paracetamol for Fever Management
2015-02-01
2016-03-01
Completed
80
An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study
2012-03-01
2014-01-01
Completed
800
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction
2017-05-10
2018-06-20
Completed
305
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
2018-03-20
2019-10-09
Completed
315
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital of Chalkida"
#1 collaborator was "Attikon Hospital" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "General Hospital Of Thessaloniki Ippokratio" with 1 trials as a collaborator and "General Hospital of Chalkida" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at General Hospital of Chalkida
According to Clinical.Site data, the most researched conditions in "General Hospital of Chalkida" are
"Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Coronary Artery Disease" (1 trials), "Fever" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "General Hospital of Chalkida" in a lesser frequency.
Clinical Trials Intervention Types at General Hospital of Chalkida
Most popular intervention types in "General Hospital of Chalkida" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "APOTEL max" (1 trials), "Empagliflozin" (1 trials) and "Neladenoson bialanate (BAY1067197)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at General Hospital of Chalkida
The vast majority of trials in "General Hospital of Chalkida" are
6 trials for "All" genders.
Clinical Trials Status at General Hospital of Chalkida
Currently, there are NaN active trials in "General Hospital of Chalkida".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in General Hospital of Chalkida,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital of Chalkida, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".